(2S,4R)-1-((S)-2-(2-fluoro-2-methylpropanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide

ID: ALA4229225

PubChem CID: 145986595

Max Phase: Preclinical

Molecular Formula: C26H35FN4O4S

Molecular Weight: 518.66

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C(C)(C)F)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C26H35FN4O4S/c1-15-20(36-14-29-15)17-9-7-16(8-10-17)12-28-22(33)19-11-18(32)13-31(19)23(34)21(25(2,3)4)30-24(35)26(5,6)27/h7-10,14,18-19,21,32H,11-13H2,1-6H3,(H,28,33)(H,30,35)/t18-,19+,21-/m1/s1

Standard InChI Key:  QZNQKYSTRCIAKT-SVFBPWRDSA-N

Molfile:  

     RDKit          2D

 36 38  0  0  0  0  0  0  0  0999 V2000
   28.6002  -24.8335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8876  -24.4210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8867  -25.2443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7419  -23.5960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4586  -23.1876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7466  -22.7712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4586  -24.8335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1730  -24.4210    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.7441  -24.4210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4586  -25.6585    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.9266  -24.7514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4786  -24.1383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0660  -23.4239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2591  -23.5955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1003  -25.5580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4887  -26.1117    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.8856  -25.8108    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.0594  -26.6172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8447  -26.8700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0167  -27.6747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8012  -27.9276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4137  -27.3737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2364  -26.5635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4521  -26.3144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1993  -27.6253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4566  -28.4054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2815  -28.4020    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.5333  -27.6163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8637  -27.1342    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   36.9744  -29.0749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0296  -24.8335    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.4016  -22.6701    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.3152  -24.4210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3152  -23.5960    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.0296  -23.1835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6006  -25.6585    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  1  3  1  0
  5  4  1  0
  4  6  1  0
  7  8  1  0
  7  9  1  0
  7 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14  8  1  0
 11 15  1  1
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 22 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 25  1  0
 26 30  1  0
  9  4  1  1
  9 31  1  0
 13 32  1  6
 31 33  1  0
 33 34  2  0
  4 35  1  0
 33  1  1  0
  1 36  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4229225

    ---

Associated Targets(Human)

VHL Tchem Von Hippel-Lindau disease tumor suppressor/Elongin B/Elongin C (158 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 518.66Molecular Weight (Monoisotopic): 518.2363AlogP: 2.98#Rotatable Bonds: 7
Polar Surface Area: 111.63Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.33CX Basic pKa: 2.65CX LogP: 1.74CX LogD: 1.74
Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.52Np Likeness Score: -0.51

References

1. Soares P, Gadd MS, Frost J, Galdeano C, Ellis L, Epemolu O, Rocha S, Read KD, Ciulli A..  (2018)  Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298).,  61  (2): [PMID:28853884] [10.1021/acs.jmedchem.7b00675]

Source